You just read:

Kyowa Hakko Kirin and Syndax Announce an Exclusive License Agreement to Develop and Commercialize Entinostat in Japan and Korea

News provided by

Syndax Pharmaceuticals, Inc.

Jan 07, 2015, 07:00 ET